TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 0 | -4 | 11 | 8 | 33 | 106 | 31 |
| S | %wins | 50 | 100 | 50 | 50 | 0 | 0 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/14 16:59 | 8/14/14 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Engler Robert | CA | D | S.d | -349 | 9.96 | 13 | -35 | -11 | 273 | D | 75 | 43 | -35 | 29 | 1 | 11 | 2 | 0 | -1 | -6 | -11 | -14 | 49 | 98 | |
5/16/14 16:26 | 5/15/14 | HALO | Halozyme Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Engler Robert | CA | D | S.d | -958 | 7.56 | 17 | -127 | -35 | 233 | D | 3 | 14 | -41 | -49 | -34 | 6 | 6 | 2 | 1 | -1 | 32 | 30 | 17 | 114 | |
3/16/07 15:25 | 3/15/07 | HTI | Halozyme Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Engler Robert | CA | D | S | -201 | 8.05 | 0 | -25 | -50 | 25 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |